Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: Relevance to immunotherapy

Clinical and Experimental Allergy

Volumn 33, Issue 9, 2003, Pages 1209-1215

  Faith, Alexander ^a   Richards, D F ^a   Verhoef, A ^b   Lamb, J R ^c   Lee, T H ^a   Hawrylowicz, C M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Allergen; Anergy; Immunotherapy; NF AT; Th2 cytokines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; PHOSPHOLIPASE A2; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CORRELATION ANALYSIS; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; T LYMPHOCYTE; TH2 CELL;

ALLERGENS; BEE VENOMS; CELL LINE; CELL NUCLEUS; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PHOSPHOLIPASES A; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, ANTIGEN, T-CELL; TH2 CELLS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; WASP VENOMS;

EID: 0042736703     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01748.x     Document Type: Article

References (37)

1. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-32.
2. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-23.
3. Walker C, Virchow JC, Bruijnzeel PLB, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma. J Immunol 1991; 145:1829-34.
4. Creticos PS. The consideration of immunotherapy in the treatment of allergic asthma. J Allergy Clin Immunol 2000; 105:559-74.
5. Rolland J, O'Hehir R. Immunotherapy of allergy: anergy, deletion, and immune deviation. Curr Opin Immunol 1998; 10:640-5.
6. Akdis AC, Akdis M, Blesken T, Wymann D, Alkan SS, Blaser K. Epitope specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98:1676-83.
7. Faith A, Akdis CA, Akdis M, Simon H-U, Blaser K. Defective TCR stimulation in anergised Type 2T helper cells correlates with abrogated p561ck and ZAP-70 tyrosine kinase activities. J Immunol 1997; 159:53-7.
8. Howe LR, Weiss A. Multiple kinases mediate T cell receptor signaling. Trends Biochem Sci 1995; 20:59-64.
9. Rao A, Luo C, Hogan PG. Transcription factors of the NF-AT family: regulation and function. Annu Rev Immunol 1997; 15:707-47.
10. Feske S, Draeger R, Peter H-H, Eichmann K, Rao A. The duration of nuclear residence of NF-AT determines the pattern of cytokine expression in human SCID T cells. J Immunol 2000; 165:297-305.
11. Yoshida H, Mishina H, Tukimoto H et al. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998; 8:115-22.
12. Ranger AM, Hodge MR, Gravallese EM et al. Delayed lymphoid repopulation with defects in IL-4 driven responses produced by inactivation of NF-ATc. Immunity 1998; 8:125-34.
13. + T-cells into effector Th1 and Th2 cells. Genes Funct 1997; 1:51-68.
14. Li-Weber M, Salgame P, Chenggang H, Davydov IV, Krammer PH. Differential interaction of nuclear factors with the PRE-1 enhancer element of the human IL-4 promoter in different T cell subsets. J Immunol 1997; 158:1194-200.
15. Li B, Tournier C, Davis RJ, Flavell RA. Regulation of IL-4 expression by the transcription factor Jun B during helper cell differentiation. EMBO J 1999; 18:420-32.
16. Verhoef A, Higgins JA, Thorpe CJ et al. Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp: identification of HLA-DR and -DQ restricted T cell epitopes. Int Immunol 1993; 5:1589-97.
17. Carballido JM, Faith A, Carballido-Perrig N, Blaser K. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur J Immunol 1997; 27:515-21.
18. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M. Induction of tolerance in influenza virus immune T lymphocytes clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983; 179:481-7.
19. + T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol 2000; 30:2344-54.
20. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995; 25:828-38.
21. Wotton D, Higgins JA, O'Hehir RE, Lamb JR, Lake RA. Differential induction of the NF-AT complex during restimulation and the induction of T cell anergy. Hum Immunol 1995; 42:95-9.
22. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease in IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
23. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27:1131-9.
24. Akdis CA, Akdis M, Blesken T et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 1996; 98:1676-83.
25. Kammerer R, Chvatchko J, Kettner A, Dufour N, Corradin G, Spertini F. Modulation of T cell response to phospholipase A2-derived peptides by conventional bee venom immunotherapy. J Allergy Clin Immunol 1997; 100:96-103.
26. Carballido JM, Faith A, Carballido-Perrig N, Blaser K. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur J Immunol 1997; 27:515-21.
27. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997; 389:737-42.
28. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000; 165:4848-53.
29. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
30. Akdis CA, Joss A, Akdis M, Faith A, Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 2000; 14:1666-8.
31. Rafiq K, Kasran A, Peng X et al. Cyclosporin A increases interferon-gamma production by T cells when co-stimulated through CD28. Eur J Immunol 1998; 28:1481-91.
32. Wierenga EA, Walchner M, Kick G, Kapsenberg ML, Weiss EH, Messer G. Evidence for suppressed activity of the transcription factor NFAT1 at its proximal binding element P0 in the IL-4 promoter associated with enhanced IL-4 gene transcription in T cells of atopic patients. Int Immunol 1999; 11:297-306.
33. Li-Weber M, Giasi M, Krammer PH. Involvement of jun and rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J Biol Chem 1998; 273:32460-6.
34. Macian F, Garcia-Rodriguez C, Rao A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 2000; 19:4783-95.
35. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002; 109:719-31.
36. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996; 184:1-8.
37. Mondino A, Whaley CD, DeSilva DR, Li W, Jenkins MK, Mueller DL. Defective transcription of the IL-2 gene is associated with impaired expression of c-fos, FosB and JunB in anergic helper 1 cells. J Immunol 1996; 157:2048-57.